Sagimet Biosciences Inc. (SGMT)
Sagimet Biosciences Inc. (SGMT) is a Healthcare stock tracked by StreetAlpha. It last closed at $9.03 on Oct 5. SGMT reports earnings on Thu, Nov 12, 2026. The average 12-month price target from 8 analysts is $26.46 (+193.1% from the last close), with a high of $56.00 and a low of $7.00. Analyst consensus is Buy, based on the latest ratings from 8 firms (7 buy, 0 hold, 1 sell). Over the past 90 days StreetAlpha recorded 1 whale options trade in SGMT, 100% of them bullish and 0% bearish. In the past 30 days there were 1 dark pool print totaling $892K, the largest $892K.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →Based on 8 analysts who set a price target on SGMT in the past 90 days. The average target is $26.46, with a high of $56.00 and a low of $7.00, compared with the last close of $9.03.
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Oct 2 | Guggenheim | Maintained | Buy | $26 |
| Oct 1 | Oppenheimer | Maintained | Buy | $38 |
| Oct 1 | Citizens | Target lowered | Buy | $29 → $27 |
| Sep 24 | Goldman Sachs | Reinstated | Sell | $7 |
| Sep 9 | Barclays | Upgrade | Buy | $18 |
Whale Options Flow
90DDark Pool
30DAI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether SGMT is in one of them and how their past SGMT trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered SGMT in an article yet. Here's the latest on the wider market.